Introduction: Hepatocellular carcinoma (HCC) is the sixth most commonly diagnosed cancer
and the third leading cause of cancer death worldwide. While there has been rapid evolution …

CLL is associated with an increased risk of infectious complications. Treatment with BTK or
BCL-2 inhibitors does not seem to increase significantly the risk of opportunistic infections …

Background & aims This systematic literature review of qualitative findings aims to identify
the perceived barriers and enablers for hepatocellular carcinoma (HCC) surveillance from …

Abstract Background & Aims The burden of metabolic dysfunction‐associated steatotic liver
disease (MASLD) is growing rapidly, as is the number of older adults globally. However …

Background Real-world hepatocellular carcinoma (HCC) surveillance uptake remains
suboptimal, despite evidence that surveillance is associated with lower cancer-related …

Abstract Issue Addressed In 2014 the 'Hep B Story App', the first hepatitis B educational app
in an Aboriginal language was released. Subsequently, in 2018, it was assessed and …

Simple Summary Cure is the goal of treatment in early primary liver cancer with surgical
resection and ablation therapy being the two most common modalities used. This real-world …

Abstract Background & Aims Chronic hepatitis B (CHB) affects populations unequally
globally, with variable prevalence and pathophysiology. Clinical trials must balance …

Prenatal and intrapartum invasive tests are possible mechanisms of mother to child
transmission (MTCT) of hepatitis B virus (HBV). The viral activity can affect the MTCT risk …

Objectives To assess the impact on diagnosis targets, cost, and cost‐effectiveness of
universal hepatitis B screening in Australia. Design Markov model simulation of disease and …